Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

mTOR-mediated cancer drug resistance suppresses autophagy and generates a druggable metabolic vulnerability
Niklas Gremke, Pierfrancesco Polo, Aaron Dort, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 123

Showing 1-25 of 123 citing articles:

PI3K/Akt/mTOR Pathway and Its Role in Cancer Therapeutics: Are We Making Headway?
Yan Peng, Yuanyuan Wang, Cheng Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 464
Attacking the PI3K/Akt/mTOR signaling pathway for targeted therapeutic treatment in human cancer
Le Yu, Jessica Wei, Pengda Liu
Seminars in Cancer Biology (2021) Vol. 85, pp. 69-94
Closed Access | Times Cited: 395
Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 259
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
Milad Ashrafizadeh, Mahshid Deldar Abad Paskeh, Sepideh Mirzaei, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 111
A proteome-wide atlas of drug mechanism of action
Dylan C. Mitchell, Miljan Kuljanin, Jiaming Li, et al.
Nature Biotechnology (2023) Vol. 41, Iss. 6, pp. 845-857
Closed Access | Times Cited: 89
HCK induces macrophage activation to promote renal inflammation and fibrosis via suppression of autophagy
Man Chen, Madhav C. Menon, Wenlin Wang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 48
Impact of cancer metabolism on therapy resistance – Clinical implications
Ana Cristina Gonçalves, Elena Richiardone, Joana Jorge, et al.
Drug Resistance Updates (2021) Vol. 59, pp. 100797-100797
Open Access | Times Cited: 90
Autophagy Regulation and Photodynamic Therapy: Insights to Improve Outcomes of Cancer Treatment
Waleska K. Martins, Renata Belotto, Maryana N. Silva, et al.
Frontiers in Oncology (2021) Vol. 10
Open Access | Times Cited: 57
The pyruvate dehydrogenase complex: Life’s essential, vulnerable and druggable energy homeostat
Peter W. Stacpoole, Charles E. McCall
Mitochondrion (2023) Vol. 70, pp. 59-102
Open Access | Times Cited: 31
Mammalian ATG8 proteins maintain autophagosomal membrane integrity through ESCRTs
Ruheena Javed, Ashish Jain, Thabata Duque, et al.
The EMBO Journal (2023) Vol. 42, Iss. 14
Closed Access | Times Cited: 30
Targeting paraptosis in cancer: opportunities and challenges
Fangquan Chen, Hu Tang, Xiutao Cai, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 3, pp. 349-363
Open Access | Times Cited: 14
Drug tolerant persister cell plasticity in cancer: A revolutionary strategy for more effective anticancer therapies
Jun He, Zejing Qiu, Jingjing Fan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs
Niklas Gremke, Isabelle Besong, A. Stroh, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
Cross talk between autophagy and oncogenic signaling pathways and implications for cancer therapy
Sahib Zada, Jin Seok Hwang, Mahmoud Ahmed, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 1, pp. 188565-188565
Open Access | Times Cited: 52
Niclosamide Ethanolamine Salt Alleviates Idiopathic Pulmonary Fibrosis by Modulating the PI3K-mTORC1 Pathway
Xiaolin Pei, Fangxu Zheng, Li Yin, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 346-346
Open Access | Times Cited: 32
Contemporary mTOR inhibitor scaffolds to diseases breakdown: A patent review (2015–2021)
Patrik Olekšák, Eugenie Nepovimová, Žofia Chrienová, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114498-114498
Closed Access | Times Cited: 29
Cadmium modulates steatosis, fibrosis, and oncogenic signaling in liver cancer cells by activating notch and AKT/mTOR pathways
Suryakant K. Niture, Sashi Gadi, Minghui Lin, et al.
Environmental Toxicology (2023) Vol. 38, Iss. 4, pp. 783-797
Open Access | Times Cited: 20
Canine melanoma: A review of diagnostics and comparative mechanisms of disease and immunotolerance in the era of the immunotherapies
Valentina B. Stevenson, Shawna Klahn, Tanya LeRoith, et al.
Frontiers in Veterinary Science (2023) Vol. 9
Open Access | Times Cited: 20
Role of mammalian target of rapamycin (mTOR) signalling in oncogenesis
Mohamed El‐Tanani, Hamdi Nsairat, Alaa A. A. Aljabali, et al.
Life Sciences (2023) Vol. 323, pp. 121662-121662
Closed Access | Times Cited: 19
Stromal cell‐derived small extracellular vesicles enhance radioresistance of prostate cancer cells via interleukin‐8‐induced autophagy
Xiumei Wang, Fan Xu, Hengyuan Kou, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 7
Open Access | Times Cited: 19
Tumor energy metabolism: implications for therapeutic targets
Youwu Hu, Wanqing Liu, WanDi Fang, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 8
The Hallmarks of Cancer as Ecologically Driven Phenotypes
Jason A. Somarelli
Frontiers in Ecology and Evolution (2021) Vol. 9
Open Access | Times Cited: 38
Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy
Álvaro Quintanal-Villalonga, Hirokazu Taniguchi, Hao Yuan, et al.
Cancer Research (2021) Vol. 82, Iss. 3, pp. 472-483
Open Access | Times Cited: 33
The Anticancer Ruthenium Compound BOLD-100 Targets Glycolysis and Generates a Metabolic Vulnerability towards Glucose Deprivation
Dina Baier, Beatrix Schoenhacker‐Alte, Mate Rusz, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 238-238
Open Access | Times Cited: 27
mTORC1 beyond anabolic metabolism: Regulation of cell death
Jiajun Zhu, Hua Wang, Xuejun Jiang
The Journal of Cell Biology (2022) Vol. 221, Iss. 12
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top